title: Plasma oxypurinol as a measure of adherence in clinical trials.
authors.affiliation: Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
authors.forename: Lisa K
authors.initials: LK
authors.lastname: Stamp
authors.affiliation: Department of Biochemistry, University of Otago, Dunedin, New Zealand.
authors.forename: Tony
authors.initials: T
authors.lastname: Merriman
authors.affiliation: Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
authors.forename: Christopher
authors.initials: C
authors.lastname: Frampton
authors.affiliation: Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.|Department of Toxicology, Canterbury Health Laboratories, Christchurch, New Zealand.
authors.forename: Mei
authors.initials: M
authors.lastname: Zhang
authors.affiliation: Deparment of Surgery, University of Otago, Dunedin, New Zealand.
authors.forename: Mary
authors.initials: M
authors.lastname: Wallace
authors.affiliation: Biology Department, Ardea Biosciences, Inc., San Diego, California, USA.
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Miner
authors.affiliation: Deparment of Medicine, University of Auckland, Auckland, New Zealand.
authors.forename: Nicola
authors.initials: N
authors.lastname: Dalbeth
mesh_terms: D000328:Adult; D000493:Allopurinol / Q000097:blood* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006074:Gout Suppressants / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010117:Oxypurinol / Q000097:blood*; D014527:Uric Acid / Q000097:blood; D016903:Drug Monitoring
chemical_list: D006074:Gout Suppressants; D014527:Uric Acid; D000493:Allopurinol; D010117:Oxypurinol
keywords: Arthritis; Gout; Treatment